Global Adipose Tissue-derived Stem Cell Therapy Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size 2017-2028

2.1.2 Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Adipose Tissue-derived Stem Cell Therapy Segment by Type

2.2.1 Autologous Stem Cells

2.2.2 Allogeneic Stem Cells

2.3 Adipose Tissue-derived Stem Cell Therapy Market Size by Type

2.3.1 Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)

2.4 Adipose Tissue-derived Stem Cell Therapy Segment by Application

2.4.1 Therapeutic Application

2.4.2 Research Application

2.5 Adipose Tissue-derived Stem Cell Therapy Market Size by Application

2.5.1 Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)

3 Adipose Tissue-derived Stem Cell Therapy Market Size by Player

3.1 Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Players

3.1.1 Global Adipose Tissue-derived Stem Cell Therapy Revenue by Players (2020-2022)

3.1.2 Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Players (2020-2022)

3.2 Global Adipose Tissue-derived Stem Cell Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Adipose Tissue-derived Stem Cell Therapy by Regions

4.1 Adipose Tissue-derived Stem Cell Therapy Market Size by Regions (2017-2022)

4.2 Americas Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2017-2022)

4.3 APAC Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2017-2022)

4.4 Europe Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2017-2022)

5.2 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022)

5.3 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2017-2022)

6.2 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022)

6.3 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Adipose Tissue-derived Stem Cell Therapy by Country (2017-2022)

7.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022)

7.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy by Region (2017-2022)

8.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022)

8.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.1 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Regions (2023-2028)

10.1.1 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Regions (2023-2028)

10.1.2 Americas Adipose Tissue-derived Stem Cell Therapy Forecast

10.1.3 APAC Adipose Tissue-derived Stem Cell Therapy Forecast

10.1.4 Europe Adipose Tissue-derived Stem Cell Therapy Forecast

10.1.5 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Forecast

10.2 Americas Adipose Tissue-derived Stem Cell Therapy Forecast by Country (2023-2028)

10.2.1 United States Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.2.2 Canada Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.2.3 Mexico Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.2.4 Brazil Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3 APAC Adipose Tissue-derived Stem Cell Therapy Forecast by Region (2023-2028)

10.3.1 China Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3.2 Japan Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3.3 Korea Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3.4 Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3.5 India Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3.6 Australia Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.4 Europe Adipose Tissue-derived Stem Cell Therapy Forecast by Country (2023-2028)

10.4.1 Germany Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.4.2 France Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.4.3 UK Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.4.4 Italy Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.4.5 Russia Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.5 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Forecast by Region (2023-2028)

10.5.1 Egypt Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.5.2 South Africa Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.5.3 Israel Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.5.4 Turkey Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.5.5 GCC Countries Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.6 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Type (2023-2028)

10.7 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 AlloCure

11.1.1 AlloCure Company Information

11.1.2 AlloCure Adipose Tissue-derived Stem Cell Therapy Product Offered

11.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 AlloCure Main Business Overview

11.1.5 AlloCure Latest Developments

11.2 Antria

11.2.1 Antria Company Information

11.2.2 Antria Adipose Tissue-derived Stem Cell Therapy Product Offered

11.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Antria Main Business Overview

11.2.5 Antria Latest Developments

11.3 Celgene Corporation

11.3.1 Celgene Corporation Company Information

11.3.2 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered

11.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Celgene Corporation Main Business Overview

11.3.5 Celgene Corporation Latest Developments

11.4 Cellleris

11.4.1 Cellleris Company Information

11.4.2 Cellleris Adipose Tissue-derived Stem Cell Therapy Product Offered

11.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Cellleris Main Business Overview

11.4.5 Cellleris Latest Developments

11.5 Corestem

11.5.1 Corestem Company Information

11.5.2 Corestem Adipose Tissue-derived Stem Cell Therapy Product Offered

11.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Corestem Main Business Overview

11.5.5 Corestem Latest Developments

11.6 Cytori Therapeutics

11.6.1 Cytori Therapeutics Company Information

11.6.2 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

11.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Cytori Therapeutics Main Business Overview

11.6.5 Cytori Therapeutics Latest Developments

11.7 Intrexon

11.7.1 Intrexon Company Information

11.7.2 Intrexon Adipose Tissue-derived Stem Cell Therapy Product Offered

11.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Intrexon Main Business Overview

11.7.5 Intrexon Latest Developments

11.8 Mesoblast

11.8.1 Mesoblast Company Information

11.8.2 Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Offered

11.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Mesoblast Main Business Overview

11.8.5 Mesoblast Latest Developments

11.9 Pluristem Therapeutics

11.9.1 Pluristem Therapeutics Company Information

11.9.2 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

11.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Pluristem Therapeutics Main Business Overview

11.9.5 Pluristem Therapeutics Latest Developments

11.10 Tissue Genesis

11.10.1 Tissue Genesis Company Information

11.10.2 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Offered

11.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Tissue Genesis Main Business Overview

11.10.5 Tissue Genesis Latest Developments

11.11 BioRestorative Therapies

11.11.1 BioRestorative Therapies Company Information

11.11.2 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Offered

11.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 BioRestorative Therapies Main Business Overview

11.11.5 BioRestorative Therapies Latest Developments

11.12 Celltex Therapeutics Corporation

11.12.1 Celltex Therapeutics Corporation Company Information

11.12.2 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered

11.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Celltex Therapeutics Corporation Main Business Overview

11.12.5 Celltex Therapeutics Corporation Latest Developments

11.13 iXCells Biotechnologies

11.13.1 iXCells Biotechnologies Company Information

11.13.2 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Offered

11.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 iXCells Biotechnologies Main Business Overview

11.13.5 iXCells Biotechnologies Latest Developments

11.14 Pluristem Therapeutics

11.14.1 Pluristem Therapeutics Company Information

11.14.2 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

11.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Pluristem Therapeutics Main Business Overview

11.14.5 Pluristem Therapeutics Latest Developments

11.15 Cyagen

11.15.1 Cyagen Company Information

11.15.2 Cyagen Adipose Tissue-derived Stem Cell Therapy Product Offered

11.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Cyagen Main Business Overview

11.15.5 Cyagen Latest Developments

11.16 Lonza

11.16.1 Lonza Company Information

11.16.2 Lonza Adipose Tissue-derived Stem Cell Therapy Product Offered

11.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Lonza Main Business Overview

11.16.5 Lonza Latest Developments

12 Research Findings and Conclusion

Table 1. Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Autologous Stem Cells

Table 3. Major Players of Allogeneic Stem Cells

Table 4. Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)

Table 7. Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)

Table 10. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Player (2020-2022)

Table 12. Adipose Tissue-derived Stem Cell Therapy Key Players Head office and Products Offered

Table 13. Adipose Tissue-derived Stem Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Regions (2017-2022)

Table 18. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Country (2017-2022)

Table 20. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)

Table 22. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)

Table 24. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Region (2017-2022)

Table 26. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)

Table 28. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)

Table 30. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Country (2017-2022)

Table 32. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)

Table 34. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Adipose Tissue-derived Stem Cell Therapy

Table 43. Key Market Challenges & Risks of Adipose Tissue-derived Stem Cell Therapy

Table 44. Key Industry Trends of Adipose Tissue-derived Stem Cell Therapy

Table 45. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 51. AlloCure Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 52. AlloCure Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 53. AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. AlloCure Main Business

Table 55. AlloCure Latest Developments

Table 56. Antria Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 57. Antria Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 58. Antria Main Business

Table 59. Antria Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Antria Latest Developments

Table 61. Celgene Corporation Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 62. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 63. Celgene Corporation Main Business

Table 64. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Celgene Corporation Latest Developments

Table 66. Cellleris Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 67. Cellleris Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 68. Cellleris Main Business

Table 69. Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Cellleris Latest Developments

Table 71. Corestem Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 72. Corestem Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 73. Corestem Main Business

Table 74. Corestem Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Corestem Latest Developments

Table 76. Cytori Therapeutics Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 77. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 78. Cytori Therapeutics Main Business

Table 79. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Cytori Therapeutics Latest Developments

Table 81. Intrexon Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 82. Intrexon Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 83. Intrexon Main Business

Table 84. Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Intrexon Latest Developments

Table 86. Mesoblast Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 87. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 88. Mesoblast Main Business

Table 89. Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Mesoblast Latest Developments

Table 91. Pluristem Therapeutics Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 92. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 93. Pluristem Therapeutics Main Business

Table 94. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Pluristem Therapeutics Latest Developments

Table 96. Tissue Genesis Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 97. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 98. Tissue Genesis Main Business

Table 99. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Tissue Genesis Latest Developments

Table 101. BioRestorative Therapies Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 102. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 103. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. BioRestorative Therapies Main Business

Table 105. BioRestorative Therapies Latest Developments

Table 106. Celltex Therapeutics Corporation Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 107. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 108. Celltex Therapeutics Corporation Main Business

Table 109. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Celltex Therapeutics Corporation Latest Developments

Table 111. iXCells Biotechnologies Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 112. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 113. iXCells Biotechnologies Main Business

Table 114. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. iXCells Biotechnologies Latest Developments

Table 116. Pluristem Therapeutics Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 117. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 118. Pluristem Therapeutics Main Business

Table 119. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Pluristem Therapeutics Latest Developments

Table 121. Cyagen Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 122. Cyagen Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 123. Cyagen Main Business

Table 124. Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. Cyagen Latest Developments

Table 126. Lonza Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 127. Lonza Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 128. Lonza Main Business

Table 129. Lonza Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Lonza Latest Developments

List of Figures

Figure 1. Adipose Tissue-derived Stem Cell Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2021

Figure 7. Adipose Tissue-derived Stem Cell Therapy in Therapeutic Application

Figure 8. Global Adipose Tissue-derived Stem Cell Therapy Market: Therapeutic Application (2017-2022) & ($ Millions)

Figure 9. Adipose Tissue-derived Stem Cell Therapy in Research Application

Figure 10. Global Adipose Tissue-derived Stem Cell Therapy Market: Research Application (2017-2022) & ($ Millions)

Figure 11. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2021

Figure 12. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Player in 2021

Figure 13. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Adipose Tissue-derived Stem Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 15. APAC Adipose Tissue-derived Stem Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 16. Europe Adipose Tissue-derived Stem Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 18. Americas Adipose Tissue-derived Stem Cell Therapy Value Market Share by Country in 2021

Figure 19. Americas Adipose Tissue-derived Stem Cell Therapy Consumption Market Share by Type in 2021

Figure 20. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2021

Figure 21. United States Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Region in 2021

Figure 26. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2021

Figure 27. China Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Country in 2021

Figure 34. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2021

Figure 35. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2021

Figure 36. Germany Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2021

Figure 44. Egypt Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 50. APAC Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 51. Europe Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 53. United States Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 54. Canada Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 57. China Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 58. Japan Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 59. Korea Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 61. India Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Australia Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 63. Germany Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 64. France Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 65. UK Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 66. Italy Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 67. Russia Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 68. Spain Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 71. Israel Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)